Dokter Kanker testis di Luar Negeri — Halaman 3

Prof. Jack Baniel memimpin departemen urologi di Rabin Medical Center, berspesialisasi dalam bedah kanker dengan teknik nerve-sparing menggunakan presisi robotik. Beliau mendirikan departemen onkourologi di Rumah Sakit Beilinson.

• Melakukan rekonstruksi kandung kemih dan prostatektomi robotik
• Menerbitkan lebih dari 100 artikel ilmiah tentang uro-onkologi
• Menjadi anggota asosiasi urologi Eropa dan Amerika
• Terlibat dalam kolaborasi penelitian klinis global

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Istinye Liv University Hospital.

• Spesialis Penyakit Dalam dengan pengalaman di berbagai klinik onkologi di Turki
• Dipromosikan menjadi Associate Professor pada tahun 2016
• Menempuh pendidikan di Fakultas Kedokteran Universitas Selcuk

30+ tahun spesialisasi dalam viroterapi – Dr. Jaunalksne memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins.

• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Kepala Pusat Imunologi Klinis – mengawasi perawatan imunologi mutakhir
• Berfokus pada pendekatan viroterapi inovatif untuk pengobatan kanker

Profesor Cemil Bilir membawa lebih dari 15 tahun pengalaman khusus dalam onkologi medis, dengan pelatihan di institusi terkemuka seperti Cleveland Clinic dan Northeastern University.

• Spesialisasi dalam mengobati kanker testis menggunakan protokol terbaru
• Menjadi anggota ASCO dan ESMO – tetap mengikuti standar global
• Mengajar calon ahli onkologi sebagai profesor di Universitas Sakarya
• Menyelesaikan fellowship di Pusat Bioteknologi Farmasi Universitas Northeastern

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Ozden memiliki lebih dari 20 tahun pengalaman dalam penyakit dalam dan onkologi medis, dengan spesialisasi kanker testis di Rumah Sakit VM Medical Park Pendik.

• Menyelesaikan subspesialisasi onkologi medis di Fakultas Kedokteran Universitas Kocaeli
• Bekerja di Rumah Sakit Swasta Safa Bağcılar dan Rumah Sakit Batı Bahat Küçükçekmece
• Lulus dari Universitas Istanbul, Fakultas Kedokteran Cerrahpaşa

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dr. Zohar Dotan heads the Urology Department at Sheba Medical Center in Israel. He is a primary pioneer of robotic and laparoscopic urologic surgery. He specializes in treating complex cancers of the kidney, prostate, and bladder. Dr. Dotan leads the Israeli Uro-Oncology Society and holds a PhD in Genetics.

• Completed a specialized uro-oncology fellowship at Memorial Sloan Kettering in New York.
• Performs robotic radical nephrectomy and da Vinci robotic prostatectomy.
• Authored over 50 scientific publications on advanced urologic cancer treatments.
• Works at Sheba Medical Center, ranked 7th best hospital globally by Newsweek.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

dr. Joseba Rebollo Liceaga memiliki pengalaman lebih dari 30 tahun di bidang onkologi, dengan spesialisasi kanker testis di Quironsalud Torrevieja.

• Kepala Onkologi di Clínica San Miguel de Navarra selama 13 tahun
• Spesialis Onkologi Medis dari Clínica Universidad de Navarra
• Penulis penelitian tentang elektrokemoterapi dan pengobatan multidisiplin
• Saat ini berpraktik di Quirónsalud Alicante

Kepala Departemen Urologi di Rambam Medical Center, Dr. Amiel spesialisasi dalam onkologi urologi.

• Pengalaman luas dalam mengobati kanker testis
• Memimpin salah satu departemen urologi terbaik di Israel
• Berfokus pada prosedur bedah onkologi

Serkan Deveci adalah seorang profesor urologi dengan fokus penelitian yang kuat pada fungsi seksual pada pasien kanker. Ia bekerja di Rumah Sakit Medical Park Göztepe dan menyelesaikan fellowship urologi utama di AS.

• Menjadi anggota American Urology Association dan North American Sexual Medicine Society
• Menjadi Editor Bagian untuk UpToDate – sumber medis terkemuka bagi para dokter
• Menulis berbagai publikasi internasional tentang kesehatan seksual pascakanker
• Melakukan penelitian tentang penanganan efek samping seperti anejakulasi setelah perawatan